Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Virtual Reality Competency-based Simulation Training Improves Early Patient Outcomes in Cataract Surgery

9 de noviembre de 2026 actualizado por: Amalie Carlsson, Copenhagen Academy for Medical Education and Simulation

The Effect of Cataract Surgical Simulation Training on Patient Outcomes

This study investigated the effect of virtual reality simulation training (VRST) on early patient outcomes following cataract surgery performed by novice surgeons. Nine novice cataract surgeons were divided into two groups based on previous VRST experience. Group allocation was determined by regional differences in simulator availability rather than randomization. Each surgeon performed three cataract surgeries before and three after completing competency-based VRST. The primary outcomes were postoperative corneal swelling and best-corrected visual acuity (BCVA), assessed preoperatively and on the first postoperative day. Phacoemulsification energy use was evaluated as a secondary outcome.

Descripción general del estudio

Estado

Terminado

Condiciones

Intervención / Tratamiento

Descripción detallada

This study investigated the effect of virtual reality simulation training (VRST) on early patient outcomes following cataract surgery performed by novice surgeons.

Nine novice cataract surgeons, each having performed fewer than ten independent cataract surgeries, were included from three regions in Denmark. Surgeons were divided into two groups based on previous VRST experience: five VRST-naïve surgeons and four VRST-experienced surgeons. Differences in previous VRST experience reflected regional variation in simulator availability, and no randomization was performed.

Each surgeon performed three cataract surgeries before and three after completing VRST on the EyeSi Surgical Simulator. Both groups received the same training intervention. All sur-geons also received standard surgical training and supervision according to routine clinical practice at their respective institutions. These training and supervision practices were not modified as part of the study.

Patients undergoing routine cataract surgery were included in the study. All patients were scheduled to undergo surgery performed by novice surgeons as part of routine clinical prac-tice, independently of study participation. Patients were not allocated to surgeons based on the study protocol, and the study did not alter their planned surgical treatment. The study-specific intervention consisted exclusively of simulation-based training provided to the sur-geons.

Patient outcomes were assessed preoperatively and on the first postoperative day. The pri-mary outcomes were postoperative corneal swelling, measured as the change in central cor-neal thickness from preoperative assessment to the first postoperative day, and best-corrected visual acuity (BCVA), assessed preoperatively and on the first postoperative day. Cumulative dissipated energy (CDE) during phacoemulsification was evaluated as a second-ary outcome.

The study aimed to investigate whether previous VRST experience was associated with dif-ferences in early patient outcomes and whether these differences changed following VRST, particularly among surgeons without previous VRST experience.

Tipo de estudio

Intervencionista

Inscripción (Actual)

54

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Copenhagen
      • Glostrup Municipality, Copenhagen, Dinamarca, 2700
        • Department of ophthalmology

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

Age >18 years.

Capacity to provide informed consent.

Scheduled to undergo cataract surgery at the Department of Ophthalmology, Rigshospitalet-Glostrup, Aarhus University Hospital, or Aalborg University Hospital.

Exclusion Criteria:

History of epiretinal membrane.

History of retinal vein occlusion.

History of retinal detachment.

History of uveitis.

Glaucoma.

Diabetes mellitus.

Exudative age-related macular degeneration (AMD) or AMD with geographical atrophy.

Inability to fully cooperate.

Shallow anterior chamber (corneal epithelium to lens <2.3 mm).

Small pupils requiring anticipated intraoperative use of a Malyugin ring.

Fuchs' endothelial dystrophy, defined as >20 central guttatae and endothelial cell density <2,000 cells/mm².

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: VRST intervention

All partiicpants regardless of previous virtual reality simulation training experience, received an virtual reality simulation training intervention after the surgeons' first 3 independent cataract operations

competency-based virtual reality simulation. The surgeons were required to train on the simulator until they were able to pass a proficiency test on the simulator

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Postoperative corneal swelling
Periodo de tiempo: 1 day

central corneal thickness (CCT) measured preoperatively and on the first postoperative day. Corneal swelling is calculated by substracting postoperative CCT from preoperative CCT

1 day
Best corrected visual acuity (BCVA)
Periodo de tiempo: 1 day

Measured preoperatively and on the first postoperative day. Part of standard evaluation and checkup on cataract surgical patients. Outcome is the calculated difference between preoperative and postoperative BCVA

1 day

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Cumulative Dissipated Phacoemulsification Energy
Periodo de tiempo: N/A measured on the day of the surgery

The amount of phacoemulsification energy used during the cataract surgical procedure

N/A measured on the day of the surgery
Intraoperative ocular pressure (IOP)
Periodo de tiempo: 1 day

IOP measured as part of the standard evaluation of the cataract patient. Measured preoperatively and on the first postoperative day

1 day
CATQUEST 7SF
Periodo de tiempo: 3 months

Questionnare of patient satisfaction with his/her vission. The patient filled out the questionnare preoperatively and 3 month postoperatively

3 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Colaboradores

Investigadores

  • Investigador principal: Ann Sofia S Thomsen, MD, PhD, Department of Ophthalmology, Rigshospitalet-Glostrup, Copenhagen, Denmark

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de agosto de 2020

Finalización primaria (Actual)

7 de noviembre de 2025

Finalización del estudio (Actual)

1 de diciembre de 2025

Fechas de registro del estudio

Enviado por primera vez

9 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

9 de noviembre de 2026

Publicado por primera vez (Actual)

13 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

13 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

9 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • H-20022813

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .